Shaw, Kaitlyn <br/><br/>
VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.  [electronic resource] 

 -  Pediatric blood & cancer  Jun 2014 
 - 1055-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.24932  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anticoagulants--administration & dosage<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Biotransformation--genetics<br/>Cardiac Surgical Procedures<br/>Child<br/>Child, Preschool<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 Enzyme System--genetics<br/>Cytochrome P450 Family 4<br/>Dose-Response Relationship, Drug<br/>Female<br/>Genetic Association Studies<br/>Genotype<br/>Hemorrhage--chemically induced<br/>Humans<br/>Infant<br/>International Normalized Ratio<br/>Male<br/>Polymorphism, Single Nucleotide<br/>Postoperative Complications--prevention & control<br/>Precision Medicine<br/>Risk<br/>Time Factors<br/>Treatment Outcome<br/>Vitamin K Epoxide Reductases--genetics<br/>Warfarin--administration & dosage